JHUNNE GALIMBA: Open Payments
NPI 1740603935 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 43 payments from 13 companies in 2025. Trend: 2023 $1,482 · 2024 $809 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $254 |
| Merck Sharp & Dohme LLC | 8 | $155 |
| Boston Scientific Corporation | 4 | $77 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $44 |
| Kestra Medical Technology Services, Inc. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: LEQVIO, VERQUVO, WATCHMAN FLX, LifeVest, Assure WCD, JARDIANCE, Wegovy, PASCAL.
Industry payments across KS — which companies pay providers there.
